0B68 Whellan - Thomas Jefferson University - Thomas Jefferson University

David J. Whellan, MD, MHS, FACC, FAHA

Contact Dr. Whellan

1015 Chestnut Street
Suite 317
Philadelphia, PA 19107

(215) 955-2007
(215) 503-7420 fax

Most Recent Peer-reviewed Publications

  1. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: Subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
  2. Conceptual model for heart failure disease management
  3. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure
  4. End-of-life care in patients with heart failure
  5. Are there negative responders to exercise training among heart failure patients?
  6. Aspirin for cardioprotection and strategies to improve patient adherence.
  7. Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: A randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study
  8. Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial)
  9. Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION)
  10. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting
  11. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function
  12. Associations between seattle heart failure model scores and health utilities: Findings from HF-ACTION
  13. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates? Findings from ASCEND-HF
  14. Family history of dilated cardiomyopathy among patients with heart failure from the HF-ACTION genetic ancillary study
  15. Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure. Results from HF-ACTION (Heart failure and a controlled trial investigating outcomes of exercise training)
  16. Saphenous vein graft disease: Review of pathophysiology, prevention, and treatment
  17. Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: Analysis from the HF-ACTION DNA substudy
  18. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)
  19. Heart Failure Patient Adherence. Epidemiology, Cause, and Treatment
  20. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics